Gilenya and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gilenya (fingolimod) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include hypokalaemia among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Gilenya and Combivent. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Gilenya?

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 111,893 Gilenya users. Check the latest studies of Gilenya.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

On Jul, 09, 2026

24 people who take Gilenya and Combivent together, and have interactions are studied.

Gilenya and Combivent drug interactions.

What are the common drug interactions of Gilenya and Combivent, by gender? *:

female:

Hypokalaemia (low potassium)
Infusion site swelling
Infusion site thrombosis
Injection site bruising
Joint swelling
Lung infection
Neuropathy peripheral (surface nerve damage)
Pain
Pneumonia
Rash

male:

Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Angioedema (rapid swelling of the dermis)
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Eyelid ptosis (falling of the upper or lower eyelid)
Fatigue (feeling of tiredness)
Gait disturbance
Heart rate decreased
Hypertension (high blood pressure)

What are the common drug interactions of Gilenya and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Infusion site thrombosis
Injection site bruising
Joint swelling
Oedema peripheral (superficial swelling)
Pain
Pneumonia
Rash
Asthenia (weakness)
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Chest discomfort

40-49:

n/a

50-59:

Weight increased
Cough
Diarrhoea
Ear infection
Fall
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Increased appetite
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)

60+:

Dyspnoea (difficult or laboured respiration)
Oedema peripheral (superficial swelling)
Red cell distribution width increased
Arteriosclerosis (thickening and hardening of arteries)
Chest discomfort
Chest pain
Glomerular filtration rate decreased
Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)
Hyperhidrosis (abnormally increased sweating)
Kidney fibrosis (excess fibrous connective tissue in kidney)

What are the existing conditions these people have? *

Wheezing (a high-pitched whistling sound made while you breath): 3 people, 12.50%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 12.50%
Hypersensitivity: 3 people, 12.50%
High Blood Cholesterol: 3 people, 12.50%
Bowel Movement Irregularity: 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Gilenya and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously